COVID-19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic.

The COVID-19 pandemic has resulted in behaviour changes among patients with AIRD. Despite the perceived risk, most of these patients continue to adhere to their prescribed medication regimens, especially maintaining the dosage of traditional immunosuppressive agents.